Nabriva raises $80M in follow-on

Nabriva Therapeutics plc (NASDAQ:NBRV) raised $80 million on Sept. 19 through the sale of 9.4 million shares at $8.50 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, SunTrust Robinson Humphrey, Needham and Wedbush. The price is a 4% discount to Nabriva's close of $8.87 on Sept. 18 when it proposed the offering after market hours...